Skip to main content
Log in

Pharmakotherapie in der Schwangerschaft und Stillzeit

Aktualisierte Kurzversion

Drug therapy during pregnancy and breast feeding

Updated summary

  • Qualitätssicherung
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Mendonca LL, Khamashta MA, Nelson-Piercy C, Hughes GRV (2000) Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology 39:880–882

    Article  PubMed  CAS  Google Scholar 

  2. Hickok DE, Hollenbach KA, Reilley SF, Nyberg DA (1989) The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol 160:1525–1531

    PubMed  CAS  Google Scholar 

  3. Vermillion ST, Scardo JA, Lashus AG, Wiles HB (1997) The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 177:256–261

    Article  PubMed  CAS  Google Scholar 

  4. Czeizel AE, Rockenbauer M (1997) Population-based case-control study of teratogenic potential of corticosteroids. Teratology 56:335–340

    Article  PubMed  CAS  Google Scholar 

  5. Park-Wyllie L, Mazzotta P, Pastuszak A et al (2000) Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385–392

    Article  PubMed  CAS  Google Scholar 

  6. Committee on Drugs. American Academy of Pediatrics (2001) The transfer of drugs and other chemicals into human milk. Pediatrics 108:776–789

    Google Scholar 

  7. Østensen M (2006) Antirheumatische Therapie und Reproduktion. Z Rheumatol 65:217–224

    Article  PubMed  Google Scholar 

  8. Wolfe MS, Cordero JF (1985) Safety of chloroquine in chemosuppression of malaria during pregnancy. BMJ 290:1466–1467

    Article  PubMed  CAS  Google Scholar 

  9. Fraga A, Mintz G, Orozco J et al (1974) Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J Rheumatol 1:293–298

    Google Scholar 

  10. Costedoat-Chalumeau N, Amoura Z, Duhaut P et al (2004) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 50:3057–3058

    Article  Google Scholar 

  11. Motta M, Tincani A, Faden D et al (2005) Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 25:86–89

    Article  PubMed  CAS  Google Scholar 

  12. Costedoat-Chalumeau N, Amoura Z, Huong du LT et al (2005) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev 4:111–115

    Article  PubMed  CAS  Google Scholar 

  13. Janssen NM, Genta MS (2000) The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation. Arch Intern Med 160:610–619

    Article  PubMed  CAS  Google Scholar 

  14. Temprano KK, Bandlamudi R, Moore TL (2005) Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 35:112–121

    Article  PubMed  CAS  Google Scholar 

  15. O’Morain C, Smethurst P, Dore CJ et al (1984) Reversible male infertility due to sulphasalazine: studies in men and rat. Gut 25:1078–1084

    Article  Google Scholar 

  16. Ferrero S, Ragni N (2004) Inflammatory Bowel Disease: Management issues during pregnancy. Arch Gynecol Obstet 270:79–85

    Article  PubMed  CAS  Google Scholar 

  17. Norgard B, Czeizel AE, Rockenbauer M et al (2001) Population based case control study of the safety of sulphasalazine use during pregnancy. Aliment Pharmacol Ther 15:483–486

    Article  PubMed  CAS  Google Scholar 

  18. Jarnerot G, Into-Malmberg MB (1979) Sulphasalazine treatment during breast feeding. Scand J Gastroenterol 14:869–871

    Article  PubMed  CAS  Google Scholar 

  19. Østensen M (2004) Disease specific problems related to drug therapy in pregnancy. Lupus 13:746–750

    Article  PubMed  Google Scholar 

  20. Hernandez-Diaz S, Werler MM, Walker AM et al (2001) Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 153:961–968

    Article  PubMed  CAS  Google Scholar 

  21. Bar Oz B, Hackman R, Einarson T et al (2001) Pregnancy outcome after cyclosporine therapy during pregnancy: A meta-analysis. Transplantation 71:1051–1055

    Article  Google Scholar 

  22. Lamarque V, Leleu MF, Monka C et al (1997) Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun. Transplant Proc 29:2480

    Article  PubMed  CAS  Google Scholar 

  23. Moskovitz DN, Bodian C, Chapman ML et al (2004) The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 99:656–661

    Article  PubMed  Google Scholar 

  24. Meehan RT, Dorsey JK (1987) Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 14:252–258

    PubMed  CAS  Google Scholar 

  25. Ramsey-Goldman R, Mientus JM, Kutzer JE et al (1993) Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol 20:1152–1157

    PubMed  CAS  Google Scholar 

  26. Østensen M (2004) Disease specific problems related to drug therapy in pregnancy. Lupus 13:746–750

    Article  PubMed  Google Scholar 

  27. Briggs GG (2005) Drugs in pregnancy and lactation, 7th edn. Lippincott Williams & Wilkins, Baltimore

  28. Zerner J, Doil KL, Drewry J, Leeber DA (1981) Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med 26:99–102

    PubMed  CAS  Google Scholar 

  29. Lloyd ME, Carr M, McElhatton P et al (1999) The effects of methotrexate on pregnancy, fertility and lactation. O J Med 92:551–563

    CAS  Google Scholar 

  30. Østensen M, Hartmann H, Salvesen K (2000) Low dose weekly methotrexate in early pregnancy: A case series and review of the literature. J Rheumatol 27:1872–1875

    PubMed  Google Scholar 

  31. Chakravarty EF, Sanchez-Yamamoto D, Bush TM (2003) The use of disease-modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: A survey of practice patterns and pregnancy outcomes. J Rheumatol 30:241–246

    PubMed  Google Scholar 

  32. Johns DG, Rutherford LD, Leighton PC et al (1972) Secretion of methotrexate into human milk. Am J Obstet Gynecol 112:978–980

    PubMed  CAS  Google Scholar 

  33. Brent RL (2001) Teratogen Update: Reproductive risks of leflunomide, a pyrimidine synthesis inhibitor. Counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 63:106–112

    Article  PubMed  CAS  Google Scholar 

  34. Boumpas DT, Austin HA, Vaughan EM et al (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366–369

    PubMed  CAS  Google Scholar 

  35. Mirkes PE (1985) Cyclophosphamide teratogenesis: A review. Teratog Carcinog Mutagen 5:75–88

    Article  PubMed  CAS  Google Scholar 

  36. Enns GM, Roeder E, Chan RT et al (1999) Apparent cyclophosphamide embryopathy: A distinct phenotype? Am J Med Genet 86:237–241

    Article  PubMed  CAS  Google Scholar 

  37. Wiernik PH, Duncan JH (1971) Cyclophosphamide in human milk. Lancet 1:912

    Article  PubMed  CAS  Google Scholar 

  38. Pergola PE, Kancharla A, Riley DJ (2001) Kidney transplantation during the first trimenon of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus and prednisone. Transplantation 71:994–997

    Article  PubMed  CAS  Google Scholar 

  39. Sifontis NM, Coscia LA, Constantinescu S et al (2006) Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82:1698–1702

    Article  PubMed  CAS  Google Scholar 

  40. Østensen M, Khamashta M, Lockshin M et al (2006) Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8:209

    Article  PubMed  Google Scholar 

  41. Strangfeld A, Listing J, Rau R et al (2007) Pregnancy outcome after exposure to biologics: Results from the German Biologics Register RABBIT. Arthritis Rheum 56 (Suppl):S 311

    Google Scholar 

  42. Katz JA, Antoni C, Keenan GF et al (2004) Outcome of pregnancy in women receiving infliximab for the treatment of crohn‘s disease and rheumatoid arthritis. Am J Gastroenterol 99:2385–2392

    Article  PubMed  Google Scholar 

  43. Orozco C, Dao K, Cush JJ et al (2005) Safety of TNF inhibitors during pregnancy in patients with inflammatory arthritis. ACR Annual Scientific Meeting San Diego, Abstr. F12

  44. Carter JD, Ladhani A, Ricca L et al (2007) A safety assessment of TNF Antagonists during pregnancy: A review of the FDA database. Arthritis Rheum 56(Suppl):S 286

    Google Scholar 

  45. Kallinich T, Haffner D, Niehues T et al (2007) Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement. Pediatrics 119:e474–e483

    Article  PubMed  Google Scholar 

  46. Berkenstad M, Weisz B, Cuckle H et al (2005) Chromosomal abnomalities and birth defects among couples with colchicine treated familial Mediterranean fever. Am J Obstet Gynecol 193:1513–1516

    Article  CAS  Google Scholar 

  47. Ben-Chetrit E, Levy M (2003) Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 62:916–919

    Article  PubMed  CAS  Google Scholar 

  48. Rabinovitch O, Zemer D, Kukia E et al (1992) Colchicine treatment in conception and pregnancy: 231 pregnancies in patients with familial Mediterranean fever

  49. Ben-Chetrit E, Berkun Y, Ben-Chetrit E et al (2004) The outcome of pregnancy in the wives of men with familial Mediterranian fever. Semin Arthritis Rheum 34:549–552

    Article  PubMed  CAS  Google Scholar 

  50. Committee on Drugs, American Academy of Pediatrics (1994) The transfer of drugs and other chemicals into human milk. Pediatrics 93:137–150

    Google Scholar 

  51. Radder CM, Roelen DL, van de Meer-Prins et al (2004) The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 191:815–820

    Article  PubMed  CAS  Google Scholar 

  52. Schaefer C, Hannemann D, Keister R et al (2006) Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 95:949–957

    PubMed  CAS  Google Scholar 

  53. Segal JB, Streiff MB, Hofmann LV et al (2007) Management of venous thromboembolism: A systematic review for a practice guideline. Ann Intern Med 146:211–222

    PubMed  Google Scholar 

  54. Bates SM, Greer IA, Pabinger I et al (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy and pregnancy. American college of chest physicians evidence-based clinical practice guidelines 8th edn. Chest 133:844–886

    Article  CAS  Google Scholar 

  55. Chan WS, Anand S, Ginsberg JS (2000) Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 160:191–196

    Article  PubMed  CAS  Google Scholar 

  56. James AH, Grotegut CA, Brancazio LR et al (2007) Thromboembolism in pregnancy: Recurrence and its prevention. Semin Perinatol 31:167–175

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to K. Krüger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krüger, K., Gromnica-Ihle, E. & im Auftrag der Kommission Pharmakotherapie der DGRh. Pharmakotherapie in der Schwangerschaft und Stillzeit. Z. Rheumatol. 68, 169–173 (2009). https://doi.org/10.1007/s00393-008-0423-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-008-0423-1

Navigation